Overview

Celgosivir as a Treatment Against Dengue

Status:
Completed

Trial end date:
2013-07-01

Target enrollment:

Participant gender:

Summary

This is a Randomized, Double-Blind, Placebo-Controlled, Phase 1b Clinical Study to Evaluate the Activity, Pharmacokinetics, Safety and Tolerability of Celgosivir in Adults with Confirmed Dengue Fever.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Singapore General Hospital

Collaborator:

Duke-NUS Graduate Medical School